Nitto Avecia Pharma Services

Biopharmaceutical Development

October 9th, 2017 by admin

Here at Avecia Pharma we are known for our scientific strength, and we pride ourselves on being on the leading edge of science, service, and seamless collaboration. With our reliable expertise, eye towards quality control, and state-of-the-art instrumentation,...
Read Full Story »

Tags: commercialization, customer focus, supply chain capabilities,

Posted in: Company News,

Nasal/Inhalation Drug Delivery Technologies

August 28th, 2017 by admin

At Avecia Pharma we provide dependable outsourcing solutions to our clients to allow them to prioritize drug development. We are committed to staying at the forefront of developing technologies and are adept at project management and reporting requirements. We...
Read Full Story »

Tags: formulation development, drug delivery, developing technology, device evaluation,

Posted in: Services,

Lung Cancer Maintenance Breakthrough

August 3rd, 2017 by admin

After seeing a drop of close to 16% off their shares, AstraZeneca got a much-needed boost in their immuno-oncology portfolio. The FDA recently handed the company a breakthrough designation for their PD-L1 med, Imfinzi, as a maintenance therapy in surgery-ineligible non-small cell lung cancer patients....
Read Full Story »

Tags: drug testing, med, lung cancer, FDA, pd-1,

Posted in: Industry News,

Nitto Denko Avecia Announces Opening of Manufacturing Expansion

July 26th, 2017 by admin

Nitto Denko Avecia Inc. (Avecia) has announced the opening of its new oligonucleotide API (active pharmaceutical ingredients) manufacturing facility in Milford, MA. The opening will commence with a ribbon cutting ceremony in August 2017 onsite at the Milford, MA facility. The ceremony will open with...
Read Full Story »

Tags: Nitto Avecia Pharma Services, changes, Nitto Avecia, News, expansion,

Posted in: Company News,

Your Partner in Analytical Development

July 13th, 2017 by admin

It can be tiring, working with several different labs and service providers, depending on the substance, dosage form, or stage of development. By teaming up with Nitto Avecia Pharma Services, you can work with us directly on any part of the process. Whether you need assistance with comparative...
Read Full Story »

Tags: analytical development,

Posted in: Services,

Our Recent Exhibits & Tours

May 17th, 2017 by admin

It's been a busy month so far at Nitto Avecia Pharma Services! We exhibited at two major industry events, both held in San Diego - the 2017 AAPS National Biotechnology Conference and the 2017 TIDES Oligonucleotide and Peptide Therapeutics Annual Meeting. These events gave us the opportunity to meet with...
Read Full Story »

Tags: Nitto Avecia Pharma Services, Facility tour, Conference, TIDES, AAPS, Biotechnology Conference,

Posted in: Company News, Facility,

TIDES: Oligonucleotide and Peptide Therapeutics

April 27th, 2017 by admin

Did you know that Avecia offers the most extensive process validation experience in the oligo industry? As part of our work in this area, we will be attending the TIDES Oligonucleotide and Peptide Therapeutics Meeting in San Diego from April 30th to May 3rd. This event is an opportunity for 90+ exhibitors...
Read Full Story »

Tags: development, News, Conference, TIDES, industry topics,

Posted in: Company News,

AAPS National Biotechnology Conference

April 25th, 2017 by admin

We will be attending the AAPS National Biotechnology Conference in San Diego from May 1st to May 3rd. This year's main topics for the conference will be: Bioanalysis & Biomarkers, Biosimilars, Emerging Topics, Formulation Development, Drug Delivery & Manufacturing, and Novel Therapeutic Constructs &...
Read Full Story »

Tags: development, News, Conference, industry topics, AAPS, Biotechnology Conference,

Posted in: Company News,

Drug Delivery Projects

April 5th, 2017 by admin

As part of our comprehensive pharma and chemistry services, our laboratories are experienced in working with drug delivery technologies. We work with transdermal and inhalation/nasal products and support our customers through every step of the development and evaluation. This includes managing the testing...
Read Full Story »

Tags: development, drug delivery, transdermal, inhalation,

Posted in: Services,

New Required Elemental Impurity Methodology

February 25th, 2017 by admin

If you are working with pharmaceutical, nutraceutical, excipient, biopharmaceutical, or medical device products, there are new General Charters for Heavy Metal impurities and contaminants that you need to be aware of. They have established new limits for acceptable levels of lead, mercury, arsenic,...
Read Full Story »

Tags: compliance, elemental impurity, methodology, UPS General Charter, heavy metals,

Posted in: Services,